Effects of particle size and adding sequence of fine lactose on the deposition of salbutamol sulphate from a dry powder formulation

被引:112
作者
Zeng, XM [1 ]
Martin, GP [1 ]
Tee, SK [1 ]
Abu Ghoush, A [1 ]
Marriott, C [1 ]
机构
[1] Kings Coll London, Dept Pharm, London SE1 8WA, England
关键词
dry powder inhalers; lactose; salbutamol sulphate; ternary mixes; dispersion; deposition;
D O I
10.1016/S0378-5173(99)00021-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Ternary mixtures composed of coarse lactose (CL) (90.8 mu m), salbutamol sulphate (SS) (5.8 mu m) and either micronised lactose (ML) (5 mu m) or intermediate sized lactose (IML) (15.9 mu m) in a ratio of 66.5:1:1 w/w were prepared using different mixing sequences of the various components. In addition, a binary mixture composed of CL and SS (67.5:1 w/w) was also prepared as the control. The in vitro deposition of SS was measured using a twin stage impinger after aerosolisation at 60 and 90 1 min(-1) via a Rotahaler(R). The aerodynamic particle size distribution of both the aerosolised SS and lactose was further analysed using an Andersen cascade impactor at 60 1 min(-1). All ternary mixtures produced a significantly higher (analysis of variance, P < 0.01) fine particle fraction (FPF) and fine particle dose (FPD) of SS than the control after aerosolisation at either 60 or 90 1 min(-1). Formulations containing the ML produced significantly (P < 0.05) higher FPF and FPD of SS than those containing the IML at both aerosolisation flow rates. Different mixing sequences were also shown to result in different deposition profiles of both SS and lactose after aerosolisation of the ternary mixtures containing ML at 60 I min(-1). The formulation prepared by first blending ML with CL before mixing with SS produced a higher FPF and FPD of SS but a lower FPF of lactose than the same formulation in terms of composition but prepared using different mixing orders of the three components. In contrast, the formulations containing IML produced a similar deposition profile to SS, regardless of the mixing sequences, and so did the formulations containing ML aerosolised at 901 min(-1). These results suggest that the effect of mixing sequences on drug deposition may become more prominent at lower aerosolisation flow rates and by reducing the size of any added fine lactose. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:133 / 144
页数:12
相关论文
共 18 条
[1]  
[Anonymous], 1992, GENERATION RESPIRABL
[2]  
Baron P.O., 1993, AEROSOL MEASUREMENT, P23
[3]   The influence of formulation on emission, deaggregation and deposition of dry powders for inhalation [J].
French, DL ;
Edwards, DA ;
Niven, RW .
JOURNAL OF AEROSOL SCIENCE, 1996, 27 (05) :769-783
[4]  
GANDERTON D, 1992, ADV PHARM SCI, V6, P165
[5]  
GONDA I, 1990, CRIT REV THER DRUG, V6, P273
[6]   ORDERED MIXING - NEW CONCEPT IN POWDER MIXING PRACTICE [J].
HERSEY, JA .
POWDER TECHNOLOGY, 1975, 11 (01) :41-44
[7]  
KASEEM NM, 1990, THESIS U LONDON
[8]   Protein deposition from dry powder inhalers: Fine particle multiplets as performance modifiers [J].
Lucas, P ;
Anderson, K ;
Staniforth, JN .
PHARMACEUTICAL RESEARCH, 1998, 15 (04) :562-569
[9]   DO PARTICLE-SIZE AND AIRWAY-OBSTRUCTION AFFECT THE DEPOSITION OF PRESSURIZED INHALATION AEROSOLS [J].
NEWMAN, SP ;
KILLIP, M ;
PAVIA, D ;
MOREN, F ;
CLARKE, SW .
THORAX, 1983, 38 (03) :233-233
[10]   CRITICAL ASPECTS OF THE FUNCTION OF INSPIRATORY FLOW DRIVEN INHALERS [J].
OLSSON, B ;
ASKING, L .
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 1994, 7 :S43-S47